Close menu

February 24th, 2022 | 10:23 CET

Lufthansa, mm2 Asia, BioNTech - Clear the way for the rebound

  • entertainment
Photo credits:

After the strong increase by the Omicron variant, the infection numbers are decreasing, and the world is breathing a sigh of relief. Due to the high vaccination rates, politicians are loosening existing restrictions. It is hard to believe, going to cinemas, restaurants and even discos is allowed again. Bookings for the travel season are increasing daily, and flying, provided you don't want to go to Kiev or Odesa at the moment, is possible at any time. Due to the almost two-year standstill, there are interesting opportunities to participate in the revived business, especially in the entertainment industry.

time to read: 4 minutes | Author: Stefan Feulner
ISIN: mm2 Asia LTD | SG1DC0000006 , LUFTHANSA AG VNA O.N. | DE0008232125 , BIONTECH SE SPON. ADRS 1 | US09075V1026

Table of contents:

    The resurrection of an industry

    If you use Facebook, the slogan "Culture isn't everything, but without culture, everything is nothing" came across your timeline in the last two years. The event industry was one of the hardest-hit industries due to closures and restrictions due to the Corona pandemic. No concerts could take place, theaters and cinemas were closed. Companies in the affected industries literally had their feet pulled out from under them overnight. In Germany, special funds were set up, and the Corona support partially prevented companies from closing overnight. Listed companies from Germany, such as CTS Eventim, halved in value in the initial phase of the pandemic but have gradually recovered to date and are already trading at pre-Corona levels.

    Great rebound opportunity in Singapore

    In other countries, or much more so on other continents, government aid was less forthcoming, which is why share price recoveries have so far failed to materialize. The example of the Singapore-based company mm2 Asia shows the great rebound potential in this sector. The Company is listed both on the main board of the Singapore Exchange and in Frankfurt at EUR 0.029 and currently has a market capitalization of EUR 77.69 million. Since the outbreak of the pandemic, the share has lost nearly 79% of its value but is now facing a strong rebound in its business following the global openings.

    At the same time, mm2 Asia is all about content. The business is divided into several sub-segments: Its core business is post-production and creation, distribution and sponsorship of content. The acquisition of a majority stake in the award-winning virtual reality, visual effects and computer-generated imagery studio, Vividthree Holdings, and an event production and concert promotion company, UnUsUaL Limited, gives it a clear competitive advantage over its peer group in this area. With the establishment of mmCineplexes and the acquisition of Cathay Cineplexes Pte Ltd, mm2 Asia is also one of the most important cinema operators in Malaysia and Singapore. In addition to the restarting cinema operations, the event production and concert promotion segment also has enormous rebound potential. Up until 2019, the Company had shone for years with rising curves in revenue and profitability. Revenue in 2019 was EUR 174.66 million, while gross profit came in at EUR 81.49 million.

    Analysts see potential

    In a report, analyst firm UOB Kay Hian expects significantly rising earnings in fiscal 2022, driven by all segments. An expected recovery in movie attendance should occur, especially as the majority of the population in Singapore and Malaysia is vaccinated. In addition, experts see a solid pipeline of core production business of EUR 98.42 million to EUR 124.67 million in the next 2-3 years and the resumption of personal concerts. Fantasy should come from the planned launch of MetaViva, an NFT marketplace. The analysts set the price target at SGD 0.115, equivalent to EUR 0.075.

    Pause for the crane

    The Lufthansa share has been recovering since mid-December of last year. From the low of EUR 5.50, it went up until the closing of the price gap at EUR 7.90. Now the airline has been brought to an abrupt halt. The reason is the Ukraine conflict and an imminent threat of war. Thus, Lufthansa stopped air traffic between Germany and the Ukrainian airports in Kiev and Odesa.

    However, the city of Lviv, located further to the west, will continue to be served by regular flights. Flights to and from Kiev and Odesa will not be suspended immediately, with flights still scheduled on Sunday "to allow people to leave Ukraine." There will be no more flights to the crisis region until the end of February. How it will continue after that, the crane airline leaves open. It is monitoring the situation and will "decide on further flights at a later date," the Handelsblatt quotes. Given the uncertainties, investors should also suspend the Lufthansa share for the time being after the increase.

    Hard hit

    From a chart perspective, the shares of vaccine manufacturer BioNTech also continue to be hit hard. After the breakout at EUR 150.00, the next support area at around EUR 120.00 could be tested. While BioNTech continues to be in negative territory, its partner Medigene exploded by almost 100% after the cooperation announcement with the Mainz-based company.

    Together, the two companies want to develop a cancer therapy over a three-year period. "This further expands our leading position in the fast-growing field of cell therapies," said Ugur Sahin, chief executive and co-founder of BioNTech. Under the terms of the collaboration, Medigene will receive an upfront payment of EUR 26 million and reimbursement of research costs. BioNTech is responsible for global development and will receive exclusive worldwide commercialization rights for the so-called TCR therapies.

    The post-pandemic openings promise enormous rebound potential, especially in the culture and events industry. In Singapore, mm2 Asia could gradually erase its share price losses of recent years. With Lufthansa and BioNTech, watching from the sidelines is recommended.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author

    Related comments:

    Commented by Stefan Feulner on May 25th, 2023 | 07:20 CEST

    Extremely strong developments in JinkoSolar, Power Nickel and CTS Eventim

    • Mining
    • Nickel
    • Solar
    • entertainment

    After the DAX reached a new all-time high, the signs are pointing towards a correction due to the ongoing lack of agreement regarding the debt ceiling in the US. The ongoing consolidation phase offers an opportunity to further optimize one's portfolio, especially with selected individual stocks. In the area of critical raw materials for the energy turnaround, disproportionate price gains await in the long term after the price losses of the past months.


    Commented by Juliane Zielonka on March 30th, 2023 | 12:15 CEST

    Saturn Oil + Gas, Bayer, Amazon - Big business on a growth path

    • Mining
    • Oil
    • Pharma
    • entertainment

    The oil industry is booming again: since Russia has been severely sanctioned, EU companies are fleeing to their international production sites to operate cost-efficiently. The winner in the energy poker is Saturn Oil & Gas. The Canadian company is now presenting its results for fiscal year 2022. What is clear is how hard the Company has worked on substance to grow steadily. Change is also felt at Bayer in the wake of the CEO change. Research in the field of women's health is discontinued, only one new blockbuster is still in the pipeline, but it is a big one. The fact that the stock market is associated with fear and greed is shown by the jump in AMC's share price. Just one piece of news from Amazon takeover rumors has investors jumping at the chance.


    Commented by Carsten Mainitz on May 17th, 2022 | 13:11 CEST

    BioNTech, mm2 Asia, TUI - Do not oversleep!

    • entertainment
    • Investments

    At least in Europe, "normality" seems to have set in in everyday life - that is, concerning Corona. However, cautionary voices are already pointing to the winter season and the associated threat of new mutations. Nevertheless, given the Ukraine war and the major security-political tensions in the world, nothing is "normal." Investors should be vigilant in following geopolitical developments and not miss out on the opportunities that continually present themselves at the corporate level.